Gene · 9739
Papers2,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Children with Early-Onset Psychosis Have Increased Burden of Rare GRIN2A Variants. | Genes (Basel) | 2023 | 37107537 | PubTator, text mining | PubMed |
| Epigenetic moonlighting: Catalytic-independent functions of histone modifiers in regulating transcription. | Sci Adv | 2023 | 37083523 | PubTator, text mining | PubMed |
| RNA binding induces an allosteric switch in Cyp33 to repress MLL1-mediated transcription. | Sci Adv | 2023 | 37075125 | PubTator, text mining | PubMed |
| New perspectives on epigenetic modifications and PARP inhibitor resistance in HR-deficient cancers. | Cancer Drug Resist | 2023 | 37065862 | PubTator, text mining | PubMed |
| Comprehensive analysis of atherosclerotic plaques reveals crucial genes and molecular mechanisms associated with plaque progression and rupture. | Front Cardiovasc Med | 2023 | 37057098 | PubTator, text mining | PubMed |
| The engagement of histone lysine methyltransferases with nucleosomes: structural basis, regulatory mechanisms, and therapeutic implications. | Protein Cell | 2023 | 37051671 | PubTator, text mining | PubMed |
| Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment. | Front Immunol | 2023 | 37033948 | PubTator, text mining | PubMed |
| Molecular insight into the SETD1A/B N-terminal region and its interaction with WDR82. | Biochem Biophys Res Commun | 2023 | 37030068 | Swiss-Prot, curated | PubMed |
| A narrative review of genetic biomarkers in non-small cell lung cancer: an update and future perspectives. | AME Med J | 2023 | 37025121 | PubTator, text mining | PubMed |
| Retraction Notice to: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically. | Mol Ther | 2023 | 37023757 | PubTator, text mining | PubMed |
| WDR5 is required for DUX4 expression and its pathological effects in FSHD muscular dystrophy. | Nucleic Acids Res | 2023 | 37021550 | PubTator, text mining | PubMed |
| Direct Lineage Reprogramming for Induced Keratinocyte Stem Cells: A Potential Approach for Skin Repair. | Stem Cells Transl Med | 2023 | 37018467 | PubTator, text mining | PubMed |
| Genomic characterization of endemic diarrheagenic Escherichia coli and Escherichia albertii from infants with diarrhea in Vietnam. | PLoS Negl Trop Dis | 2023 | 37014918 | PubTator, text mining | PubMed |
| The effect of level-marked mathematics tasks on students' self-efficacy: An experimental study. | Front Psychol | 2023 | 37008836 | PubTator, text mining | PubMed |
| Continuous Large Area Monolayered Molybdenum Disulfide Growth Using Atmospheric Pressure Chemical Vapor Deposition. | ACS Omega | 2023 | 37008105 | PubTator, text mining | PubMed |
| A Computational Approach to Predict the Role of Genetic Alterations in Methyltransferase Histones Genes With Implications in Liver Cancer. | Cancer Inform | 2023 | 37008071 | PubTator, text mining | PubMed |
| Novel mutation in the SETD1A gene in a newborn patient associating with congenital airway and heart defeats: A case report. | Medicine (Baltimore) | 2023 | 37000069 | PubTator, text mining | PubMed |
| Epigenetic Targets in Schizophrenia Development and Therapy. | Brain Sci | 2023 | 36979236 | PubTator, text mining | PubMed |
| METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation. | Cell Death Dis | 2023 | 36977668 | PubTator, text mining | PubMed |
| Hemostatic spray (TC-325) vs. standard endoscopic therapy for non-variceal gastrointestinal bleeding: A meta-analysis of randomized controlled trials. | Endosc Int Open | 2023 | 36968978 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9739/papers?page=15